EQUELS THOMAS K.

AIM

EQUELS THOMAS K. serves as CEO & President at AIM ImmunoTech Inc. (AIM). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$55.0K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$55.0K

Companies Traded

AIM

Active Period

Feb 2021 – Jul 2021

2 total trades

Most Recent

Buy AIM

Jul 16, 2021 · $30.0K

EQUELS THOMAS K.'s Insider Trading at AIM ImmunoTech Inc. (AIM)

Buys

2 · $55.0K

Sells

0 · $0.00

Total Shares Bought

26,687

Total Shares Sold

AIM Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jul 16, 2021	Buy	15,625	$1.92	$30.0K	0
Feb 24, 2021	Buy	11,062	$2.26	$25.0K	0

Related Insiders

Thomas K Equels

director, officer: CEO & President

AIMBuy · Sep 15, 2026

Explore More Insider Trading Data

AIM Insider Trading Activity

View all insider trades at AIM ImmunoTech Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity